HaploX Stock

haplox.cnHealthcareFounded: 2014Funding to Date: $42.87MM

HaploX aims to integrate liquid biopsy technology, gene sequencing, artificial intelligence, big data, and other technologies to improve the management of cancer patients.

Register for Details

For more details on financing and valuation for HaploX, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for HaploX.

Register Today

Team

Management Team

Wen Yuan
Chief Financial Officer & Co-Founder
Fang Wen
Chief Operating Officer & Co-Founder
Chen Shifu Ph.D
Chief Technology Officer & Co-Founder
Yan Ming Xu Ph.D
Co-Founder, Chief Executive Officer & Chairman

Board Members

Yan Ming Xu Ph.D

Other companies like HaploX in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 

News

A group of investors including SBCVC and Kexin Capital have backed a $32 million funding round for China’s HaploX Biotechnology. ,Greater China,Healthcare,Technology,Early-stage ,China,Softbank China Venture Capital,Venture